Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase II study of anti-PD-1/PD-L1 plus celecoxib
2019-000572-41Phase 2Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib in cancer, sponsored by Cliniques universitaires Saint-Luc. Started Mar 2019; status: completed.
02
Drugs
celecoxib
03
Conditions
cancer
Beyond the preview
Go deeper on 2019-000572-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000572-41.